Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
52
pubmed:dateCreated
2003-12-22
pubmed:abstractText
Surfactant Protein C (SP-C) is a secreted transmembrane protein that is exclusively expressed by alveolar type II epithelial cells of the lung. SP-C associates with surfactant lipids to reduce surface tension within the alveolus, maintaining lung volume at end expiration. Mutations in the gene encoding SP-C (SFTPC) have recently been linked to chronic lung disease in children and adults. The goal of this study was to determine whether a disease-linked mutation in SFTPC causes lung disease in transgenic mice. The SFTPC mutation, designated g.1728 G --> A, results in the deletion of exon4, generating a truncated form of SP-C (SP-C(Deltaexon4)). cDNA encoding SP-C(Deltaexon4) was constitutively expressed in type II epithelial cells of transgenic mice. Viable F0 transgene-positive mice were not generated after two separate rounds of pronuclear injections. Histological analysis of lung tissue harvested from embryonic day 17.5 F0 transgene-positive fetuses revealed that SP-C(Deltaexon4) caused a dose-dependent disruption in branching morphogenesis of the lung associated with epithelial cell cytotoxicity. Transient expression of SP-C(Deltaexon4) in isolated type II epithelial cells or HEK293 cells resulted in incomplete processing of the mutant proprotein, a dose-dependent increase in BiP transcription, trapping of the proprotein in the endoplasmic reticulum, and rapid degradation via a proteasome-dependent pathway. Taken together, these data suggest that the g.1728 G --> A mutation causes misfolding of the SP-C proprotein with subsequent induction of the unfolded protein response and endoplasmic reticulum-associated degradation pathways ultimately resulting in disrupted lung morphogenesis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
26
pubmed:volume
278
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
52739-46
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:14525980-Animals, pubmed-meshheading:14525980-Blotting, Western, pubmed-meshheading:14525980-Carrier Proteins, pubmed-meshheading:14525980-Cell Line, pubmed-meshheading:14525980-DNA, pubmed-meshheading:14525980-DNA, Complementary, pubmed-meshheading:14525980-Dose-Response Relationship, Drug, pubmed-meshheading:14525980-Endoplasmic Reticulum, pubmed-meshheading:14525980-Exons, pubmed-meshheading:14525980-Gene Deletion, pubmed-meshheading:14525980-Heat-Shock Proteins, pubmed-meshheading:14525980-Humans, pubmed-meshheading:14525980-Lipid Metabolism, pubmed-meshheading:14525980-Luciferases, pubmed-meshheading:14525980-Lung, pubmed-meshheading:14525980-Lung Diseases, pubmed-meshheading:14525980-Mice, pubmed-meshheading:14525980-Mice, Transgenic, pubmed-meshheading:14525980-Microscopy, Fluorescence, pubmed-meshheading:14525980-Models, Genetic, pubmed-meshheading:14525980-Molecular Chaperones, pubmed-meshheading:14525980-Mutation, pubmed-meshheading:14525980-Peptides, pubmed-meshheading:14525980-Phenotype, pubmed-meshheading:14525980-Protein Binding, pubmed-meshheading:14525980-Protein Folding, pubmed-meshheading:14525980-Protein Transport, pubmed-meshheading:14525980-Pulmonary Surfactant-Associated Protein C, pubmed-meshheading:14525980-Time Factors, pubmed-meshheading:14525980-Transcription, Genetic, pubmed-meshheading:14525980-Transfection, pubmed-meshheading:14525980-Transgenes
pubmed:year
2003
pubmed:articleTitle
Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice.
pubmed:affiliation
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't